Scandinavian Tobacco Group AS (0RES)
London Exchange · UK · prices in DKK · close of 21 Oct 2026
Key indicators
| Last close | DKK 77.85 |
|---|---|
| 52-week range | 59.91 – 97.02 |
| Return, 1 month / 3 months | +5.6% / +11.1% |
| Return, 1 year / 3 years | −3.3% / −4.7% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 39.5% |
| Worst drawdown (1 year) | -36.1% |
| Average daily value traded | 0.25M DKK |
| Dividend yield | 5.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Scandinavian Tobacco Group is a Danish maker of tobacco products, based in Copenhagen. The company produces cigars, cigarillos, pipe tobacco and fine-cut tobacco, and it also sells smoking accessories. Its brands are familiar to adult tobacco consumers in Europe and North America, and its products reach shops, tobacconists and distributors in many countries. The business combines machine-made and handmade cigar production with pipe and roll-your-own tobacco, serving both everyday and specialty segments of the tobacco market.
The shares are listed on the London Exchange in UK under the code 0RES, and the price on this page is in Danish kroner (DKK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Scandinavian Tobacco Group AS (0RES) trades on the London Exchange in UK. It last closed at DKK 77.85 on 21 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 2,003 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.3% and over the last three months it rose 11.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.2% | ||
| From 52-week high | -18.9% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.1% | ||
| 6-month return | 21.1% | ||
| 12-month return, skipping the last month | -8.4% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.1% | ||
| Liquidity | 39 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.25M DKK | ||
| Zero-volume days | 1.7% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.4% |
|---|---|
| 1 month | +5.6% |
| 3 months | +11.1% |
| 6 months | +21.1% |
| 1 year | −3.3% |
| 3 years | −4.7% |
| 5 years | −22.2% |
Signals
| 50-day / 200-day average | 73.88 / 73.98 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.14 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Apr 2026 | DKK 4.5000 |
| 10 Apr 2025 | DKK 8.5000 |
| 5 Apr 2024 | DKK 8.4000 |
| 14 Apr 2023 | DKK 8.2500 |
| 1 Apr 2022 | DKK 7.5000 |
| 15 Apr 2021 | DKK 6.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.